Laboratory Products


Nov 01 2007

Author: S. Raghuraman and Dr. Lai Weng Chuen on behalf of Eutech Instruments Pte Ltd

Free to read

This article has been unlocked and is ready to read.


The 21 CFR Part 11 was effected in 1997 by the US Food & Drug Administration (FDA) to encourage wider use of electronic data technology. With predicate regulations such as GMP, GLP and GCP as its base, Part 11 delineates a set of criteria to implement control, validation and audit trail on electronic data that are meant to replace written documents as equivalents. Although necessary to preserve data integrity, Part 11 remains one of the most challenging regulations imposed by the FDA on the biotechnological and pharmaceutical industries, directly affecting all systems that generate, store and use electronic data which fall under the predicate regulations. In August 2003, after gathering significant industry feedback, FDA released the guidance draft ?Industry Guide, Part 11, Electronic Records; Electronic Signatures ? Scope and Application?. Through this scope and Application Guide, the agency announced a narrowed scope of Part 11 with enforcement discretion exercised on items such as computerised systems validation, time-stamped audit trails, and methods used to reproduce and retain electronic records. This guide remains relevant today, pending a revised version of the Part 11 regulation to be released by FDA.

Free to read

This article has been unlocked and is ready to read.


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions


ASMS Conference

Jun 02 2024 Anaheim, CA, USA


Jun 10 2024 Frankfurt, Germany

Lab & Test Asia

Jun 12 2024 Bangkok, Thailand

Chemspec Europe 2024

Jun 19 2024 Dusseldorf, Germany

Forensics Europe Expo

Jun 19 2024 London, UK

View all events